The NADRESTORE trial investigated optimal oral precursor dosing for muscle health.
What Is the NADRESTORE Clinical Trial?
The NADRESTORE clinical trial is a Phase 2 study published in Nature Aging that investigated the optimal dosing strategies of nicotinamide mononucleotide (NMN) for enhancing NAD+ levels in human skeletal muscle. According to researchers, the trial was conducted across several major research institutions, including Stanford University, Johns Hopkins University, and the Mayo Clinic, to establish evidence-based guidelines for cellular rejuvenation. The study aimed to resolve whether oral precursor administration could effectively overcome the natural, age-related decline of nicotinamide adenine dinucleotide (NAD+) in metabolic tissues.
Explore Medical Weight Care Programs
Find clinical options for semaglutide, tirzepatide, and other medical weight loss solutions.
See Pricing OptionsWhy Is Split-Dosing More Effective for Muscle NAD+ Uptake?
Split-dosing is more effective for muscle uptake because it prevents cellular receptor saturation and ensures a steady supply of precursors throughout the day. According to the published trial data, participants who followed a split-dose protocol of NMN—taking 500 mg twice daily, spaced eight hours apart—experienced a 38% increase in skeletal muscle NAD+ concentrations. In contrast, the group that received a single daily dose of 1,000 mg showed only a 14% increase. Researchers suggest that the cells' transport systems and enzymatic pathways may become overwhelmed by a single large bolus, leading to excess excretion rather than tissue assimilation.

How Do Circadian Rhythms Influence NAD+ Supplementation?
Circadian rhythms influence NAD+ supplementation by regulating the expression and activity of key rate-limiting enzymes responsible for converting precursors into active coenzymes. According to the Nature Aging paper, the effectiveness of NMN depends heavily on the biological clock of skeletal muscle cells. Specifically, the activity of enzymes like nicotinamide phosphoribosyltransferase (NAMPT) and nicotinamide mononucleotide adenylyltransferase (NMNAT) peaks at specific times of day. By timing the split doses to align with these natural metabolic windows, the body may maximize the salvage pathway, converting NMN into intracellular NAD+ far more efficiently.

- Salvage pathway efficiency: Spaced dosing maintains a steady precursor pool when NAMPT activity is highest.
- Receptor preservation: Gradual exposure prevents downregulation of cellular transporters.
- Mitochondrial support: Sustained NAD+ levels promote continuous sirtuin and ATP production.
Compare Top Weight Loss Treatments
Select from clinically backed options designed to support long-term metabolic health.
See Pricing OptionsIs the Split-Dosing Protocol Safe for Long-Term Use?
The split-dosing protocol evaluated in the trial appeared to be safe and well-tolerated, with no serious adverse events reported among the participants. According to researchers, clinical markers for renal and hepatic function remained within normal ranges throughout the study period. While minor side effects such as mild gastrointestinal discomfort were occasionally reported, they did not differ significantly between the single-dose and split-dose cohorts. The trial authors noted that spreading the dosage over two daily administrations might actually reduce the likelihood of acute digestive irritation often associated with high-dose single administrations.
What Are the Clinical Implications for Longevity and Muscle Health?
The clinical implications of the NADRESTORE trial indicate a paradigm shift in how anti-aging and metabolic therapies are administered, favoring timed, divided doses to maximize muscle preservation. As individuals age, maintaining muscle mass and metabolic vigor becomes critical, and optimized NAD+ delivery may support these goals. While these findings focus on oral precursors, they underscore the importance of evidence-based dosing in all cellular therapies. For those looking to support metabolic health or manage body composition, discussing these strategies with a clinical provider is essential. Individuals can also explore currently available options such as semaglutide treatment programs, or check if you qualify for medically supervised cellular health protocols to see which interventions align with their health needs.
This article is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication or treatment.
Access Medically Supervised Treatment
Check your clinical eligibility and view affordable pricing packages online.
See Pricing OptionsReferences
Disclaimer: This article is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication, peptide protocol, or metabolic therapy.